REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

1,237 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2022.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,061 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 82.2M shares of 105M outstanding shares and own 78.27% of the company stock.
Largest 10 shareholders include FMR LLC (9.98M shares), VANGUARD GROUP INC (8.36M shares), Capital World Investors (5.95M shares), STATE STREET CORP (5.13M shares), JPMORGAN CHASE & CO (4.96M shares), WELLINGTON MANAGEMENT GROUP LLP (2.89M shares), LOOMIS SAYLES & CO L P (2.55M shares), Dodge & Cox (2.24M shares), GEODE CAPITAL MANAGEMENT, LLC (2.09M shares), and Capital International Investors (1.68M shares).
This table shows the top 1061 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.